TickerFacts.

Cencora, Inc. (COR): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2011-09-30 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$309.85B
Year ended 2025-09-30
$319.55B
Trailing 12 months to 2026-06-30
+10.4%
3-year compound annual growth
+10.9%
5-year compound annual growth
+8.9%
10-year compound annual growth
2007-09-30: $63.45B2008-09-30: $68.14B2009-09-30: $69.66B2010-09-30: $75.45B2011-09-30: $76.24B2012-09-30: $75.45B2013-09-30: $85.45B2014-09-30: $116.59B2015-09-30: $132.43B2016-09-30: $142.58B2017-09-30: $148.60B2018-09-30: $163.33B2019-09-30: $174.45B2020-09-30: $184.70B2021-09-30: $207.05B2022-09-30: $230.29B2023-09-30: $253.21B2024-09-30: $284.05B2025-09-30: $309.85B$309.85B
2007-09-30 Cost of Revenue (USD) 2025-09-30
Period endedCost of RevenueChange YoYSource filing
2025-09-30$309.85B+9.1%2025-11-25, From 2024-10-01
2024-09-30$284.05B+12.2%2025-11-25, From 2023-10-01
2023-09-30$253.21B+10.0%2025-11-25, From 2022-10-01
2022-09-30$230.29B+11.2%2024-11-26, From 2021-10-01
2021-09-30$207.05B+12.1%2023-11-21, From 2020-10-01
2020-09-30$184.70B+5.9%2022-11-22, From 2019-10-01
2019-09-30$174.45B+6.8%2021-11-23, From 2018-10-01
2018-09-30$163.33B+9.9%2020-11-19, From 2017-10-01
2017-09-30$148.60B+4.2%2019-11-19, From 2016-10-01
2016-09-30$142.58B+7.7%2018-11-20, From 2015-10-01
2015-09-30$132.43B+13.6%2017-11-21, From 2014-10-01
2014-09-30$116.59B+36.4%2016-11-22, From 2013-10-01
2013-09-30$85.45B+13.3%2015-11-24, From 2012-10-01
2012-09-30$75.45B-1.0%2014-11-25, From 2011-10-01
2011-09-30$76.24Bn/c2013-11-26, From 2010-10-01
2010-09-30$75.45B+8.3%2012-11-27, From 2009-10-01
2009-09-30$69.66B+2.2%2011-11-22, From 2008-10-01
2008-09-30$68.14B+7.4%2010-11-23, From 2007-10-01
2007-09-30$63.45Bn/a2009-11-25, From 2006-10-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Wholesale-Drugs, Proprietaries & Druggists' Sundries), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Cencora, Inc. (COR)2025-09-30$309.85B+9.1%
McKesson Corp (MCK)2026-03-31$388.88B+12.5%
Cardinal Health Inc (CAH)2026-06-30$244.47B+14.0%
Herbalife Ltd. (HLF)2025-12-31$1.11B+0.9%
Nu Skin Enterprises, Inc. (NUS)2025-12-31$453.76M-17.5%
Cosmos Health Inc. (COSM)2025-12-31$57.38M+14.5%
DataMeds AI, Inc. (MEDS)2025-12-31$29.76M+81.9%
Stemtech Corp (STEK)2025-12-31$566.9K-57.3%
HWH International Inc. (ESYN)2025-12-31$407.2K-37.5%

Compare COR, MCK, CAH, HLF side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗